Diaceutics enters into strategic
alliance with KPMG
Alliance will facilitate joint
marketing of commercialisation solutions to life science customers
launching precision medicines
Combines Diaceutics' and KPMG's
extensive data, expertise and reputation in commercialising
precision medicines with pharma and biotech
customers
Belfast and London, 14 February 2024 - Diaceutics PLC (AIM:
DXRX), a leading technology and
solutions provider to pharma and biotech customers is pleased
to announce a strategic alliance with KPMG LLP (KPMG), a global
leader in tax, audit and advisory services and commercialisation
solutions for the healthcare and life sciences industries. The goal
of the alliance is to bring together Diaceutics' leading technology
solutions, which help pharma companies find
appropriate patients for their precision medicines, and KPMG's
market-leading advisory business. This strategic alliance will
combine Diaceutics' and KPMG's extensive knowledge, expertise and
industry reputation, and build on their significant individual
successes in organically and inorganically transforming precision
medicine businesses and commercialising precision medicines over
multiple years.
Ryan Keeling, Diaceutics' Chief
Executive Officer, commented:
'It is great to see this partnership
come to life. We have worked alongside KPMG leaders for many years
with a strong admiration for their work in the precision medicine
space. This alliance formally recognises our common goals and
ambitions to collectively shape the future of precision medicine.
Between the two organisations we have worked on many of the
precision medicine therapies currently on market. This alliance
will make it easier for the world's largest and most innovative
pharmaceutical and biotech organisations to get access to the best
expertise and the best data available."
Kristin Pothier, KPMG, Life Sciences Sector Leader and Global
HCLS Deal Advisory and Strategy Leader,
commented:
"We look
forward to formalising our long-standing collaboration with
Diaceutics with this strategic alliance and to the opportunity this
presents. Diaceutics' unrivalled data resource and industry
expertise, combined with our proprietary data, our global customer
base and our experience across precision medicine commercialisation
and deal making, creates a strengthened capability to help our
clients commercialise precision medicine products and services
worldwide, and evolve the provision of
healthcare."
Diaceutics is becoming the commercialisation
partner of choice for pharma and biotech companies launching
precision medicines and counts 21 of the top 30 global pharma
companies amongst its customers. KPMG is a market-leading and
globally recognised provider of tax, audit, and advisory services
to the world's leading healthcare and life sciences companies.
Through its strategic alliance partnerships, it has successfully
built an ecosystem of the world's leading technology brands,
allowing KPMG to combine these alliances with its
expertise to bring transformative technologies to its
clients.
The power of more
efficient diagnostic pathways to improve treatment
outcomes is proven. These are, in turn, driving the shift to
precision medicine across the healthcare and life sciences
ecosystem. Diaceutics and KPMG believe there is a strategic
opportunity to align their advisory and data
enabled commercialisation solutions to support this ecosystem
in harnessing the clinical and economic returns that precision
medicine can deliver.
This strategic alliance will
identify opportunities to enable both Diaceutics and KPMG to
jointly market their commercialisation solutions to new and
existing customers, globally, and explore other areas of mutual
benefit whilst demonstrating their shared dedication to shaping the
future of precision medicine, and supporting our clients in
bringing life changing medicines to patients. Notably, both
management teams have independently played pivotal roles in the
launch of the majority of significant companion diagnostics and
their associated therapeutics to have come to market.
The collaborative expertise of both
KPMG and Diaceutics positions them at the forefront of advancing
the industry's capabilities in the evolving landscape of healthcare
decisions, driven through real-world data insights.
This announcement contains inside
information for the purposes of Article 7 of Regulation (EU)
596/2014 as it forms part of UK domestic law by virtue of the
European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in
accordance with the Company's obligations under Article 17 of MAR.
The person responsible for making this announcement on behalf of
the Company is Nick Roberts, Chief Financial Officer.
Enquiries:
Diaceutics
PLC
|
|
Ryan Keeling, Chief Executive
Officer
Nick Roberts, Chief Financial
Officer
|
Tel: +44 (0)28 9040 6500
investorrelations@diaceutics.com
|
|
|
Stifel
Nicolaus Europe Limited (Nomad &
Broker)
|
Tel: +44 (0)20 7710 7600
|
Ben Maddison
|
|
Nick Harland
|
|
Kate Hanshaw
|
|
|
|
Alma Strategic
Communications
|
Tel: +44(0)20 3405 0205
|
Caroline Forde
|
diaceutics@almastrategic.com
|
Kinvara Verdon
KPMG
LLP
Kristin Pothier, Life Sciences Sector
Leader
Alasdair Milton, Principal, KPMG Life Sciences Strategy
|
us-hclspractice@kpmg.com
|
|
|
About Diaceutics
At Diaceutics we believe that every
patient should get the opportunity to receive the right test and
the right therapy to positively impact their disease
outcome.
We provide the world's leading
pharma and biotech companies with an end-to-end commercialisation
solution for precision medicines through data analytics, scientific
and advisory services enabled by our platform DXRX - The
Diagnostics Network ®
About KPMG
KPMG LLP is one of the largest providers of
professional services-advisory, strategy, audit, and tax- to the
healthcare and life sciences industry globally with more than 4,200
healthcare and life sciences industry-specific partners and
professionals. Our precision medicine expertise spans the globe and
helps provide strategic and tactical solutions devoted to the
future of medicine. For more information: Precision
Medicine (kpmg.us)